| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to specialized treatment by adult Hispanic brain tumor patients: findings from a single-institution retrospective study
|
Nashed, Mark
|
|
2012
|
|
9 |
p. 283-288
6 p.
|
artikel
|
| 2 |
Acute megakaryoblastic leukemia with an associated vaginal myeloid sarcoma
|
Lash, Bradley W.
|
|
2011
|
|
9 |
p. 410-414
5 p.
|
artikel
|
| 3 |
A dispensing pharmacy: is it right for your community practice?
|
Reagan, Michael
|
|
2006
|
|
9 |
p. 603-604
2 p.
|
artikel
|
| 4 |
A milestone, yes, but many questions remain unanswered
|
Agarwala, Sanjiv S.
|
|
2010
|
|
9 |
p. 398-
1 p.
|
artikel
|
| 5 |
Antiangiogenic therapy for malignant glioma
|
Altaha, Ramin
|
|
2009
|
|
9 |
p. 399-400
2 p.
|
artikel
|
| 6 |
A physicians-only Web site: building an intellectual and activist community online
|
Young, Patrick
|
|
2008
|
|
9 |
p. 521-524
4 p.
|
artikel
|
| 7 |
Assessing the combination of FOLFOX or FOLFIRI with bevacizumab, cetuximab, or both in metastatic colorectal cancer
|
Venook, Alan P.
|
|
2006
|
|
9 |
p. 593-598
6 p.
|
artikel
|
| 8 |
Assessing the risk of breast cancer recurrence in node-positive patients with Oncotype DX and Adjuvant!
|
Abraham, Jame
|
|
2008
|
|
9 |
p. 485-487
3 p.
|
artikel
|
| 9 |
A step forward in predicting outcomes
|
Laufman, Leslie R.
|
|
2008
|
|
9 |
p. 487-488
2 p.
|
artikel
|
| 10 |
Becoming smarter about parenteral iron use in the oncology clinic
|
Steensma, David P.
|
|
2012
|
|
9 |
p. 274-276
3 p.
|
artikel
|
| 11 |
Bevacizumab in recurrent glioblastoma
|
Abraham, Jame
|
|
2009
|
|
9 |
p. 397-399
3 p.
|
artikel
|
| 12 |
Bortezomib for myeloma: optimizing treatment strategies
|
Kumar, Shaji K.
|
|
2012
|
|
9 |
p. 272-273
2 p.
|
artikel
|
| 13 |
Breast cancer: a father's legacy
|
|
|
2008
|
|
9 |
p. 513-514
2 p.
|
artikel
|
| 14 |
Cancer disparities research in community hospitals
|
Klewien, Barbara A.
|
|
2010
|
|
9 |
p. 419-424
6 p.
|
artikel
|
| 15 |
Carfilzomib and bortezomib therapy in patients with multiple myeloma
|
Abraham, Jame
|
|
2012
|
|
9 |
p. 278-282
5 p.
|
artikel
|
| 16 |
Carfilzomib for myeloma: proteasome inhibition with a different flavor?
|
Kumar, Shaji K.
|
|
2012
|
|
9 |
p. 270-271
2 p.
|
artikel
|
| 17 |
Change as the constant
|
Schwartzberg, Lee S.
|
|
2008
|
|
9 |
p. 483-
1 p.
|
artikel
|
| 18 |
Changing standards of care
|
Schwartzberg, Lee S.
|
|
2007
|
|
9 |
p. 517-
1 p.
|
artikel
|
| 19 |
Chemotherapeutics and cardiac toxicity: treatment considerations and management strategies
|
Safra, Tamar
|
|
2007
|
|
9 |
p. 540-548
9 p.
|
artikel
|
| 20 |
Choosing a pharmacy model and a dispensing method
|
Smith, Jennie
|
|
2006
|
|
9 |
p. 606-
1 p.
|
artikel
|
| 21 |
Circulating tumor cells: ready for prime time
|
Sabbath, Kert D.
|
|
2008
|
|
9 |
p. 516-520
5 p.
|
artikel
|
| 22 |
Clinical and patient-reported outcomes based on achieved hemoglobin levels in chemotherapy-treated cancer patients receiving erythropoiesis-stimulating agents
|
Larholt, Kay
|
|
2009
|
|
9 |
p. 403-408
6 p.
|
artikel
|
| 23 |
Clopidogrel-associated TTP: the next chapter
|
Samaras, Athena
|
|
2008
|
|
9 |
p. 496-497
2 p.
|
artikel
|
| 24 |
CMS restricts use of ESAs in cancer patients
|
Okon, Ted
|
|
2007
|
|
9 |
p. 565-
1 p.
|
artikel
|
| 25 |
Commentary by Kami Wolfe Schneider, MS, CGC, Baptish Memorial Health Care, Memphis, TN
|
|
|
2008
|
|
9 |
p. 514-
1 p.
|
artikel
|
| 26 |
Commentary by Sue Friedman, Board Chair, FORCE, Tampa, FL
|
|
|
2008
|
|
9 |
p. 513-
1 p.
|
artikel
|
| 27 |
Community Oncology Editors' practice changers
|
Henry, David H.
|
|
2012
|
|
9 |
p. 298-300
3 p.
|
artikel
|
| 28 |
Complete remission of metastatic Ewing's sarcoma/primitive neuroectodermal tumor with standard chemotherapy
|
Jasani, Nikesh
|
|
2007
|
|
9 |
p. 567-568
2 p.
|
artikel
|
| 29 |
Counting what really counts: the irinotecan in recurrent glioblastoma trial
|
Streiner, David L.
|
|
2011
|
|
9 |
p. 425-426
2 p.
|
artikel
|
| 30 |
Depression in the patient with brain cancer
|
Pangilinan Jr, Percival H.
|
|
2007
|
|
9 |
p. 533-537
5 p.
|
artikel
|
| 31 |
Detecting office fraud in your practice
|
Webster, Lee Ann H.
|
|
2009
|
|
9 |
p. 412-415
4 p.
|
artikel
|
| 32 |
Diagnostic testing
|
Streiner, David L.
|
|
2009
|
|
9 |
p. 428-430
3 p.
|
artikel
|
| 33 |
Direct-to-consumer genetic testing and its potential impact on patient care: what oncologists need to know
|
Gray, Stacy W.
|
|
2011
|
|
9 |
p. 419-422
4 p.
|
artikel
|
| 34 |
Electronic medical records and standardized data could mean a boost in clinical trials enrollment
|
Bongiorno, Natalie
|
|
2007
|
|
9 |
p. 557-558
2 p.
|
artikel
|
| 35 |
Emerging therapies for metastatic carcinoma to the liver
|
Tanabe, Kenneth K.
|
|
2006
|
|
9 |
p. 567-570
4 p.
|
artikel
|
| 36 |
Experience with maintenance rituximab after chemotherapy in patients with low-grade lymphoma
|
Ayoola, Ayodele
|
|
2010
|
|
9 |
p. 414-417
4 p.
|
artikel
|
| 37 |
FDA skirts esophageal cancer risk with bisphosphonates; duration of use takes precedence
|
Berman-Gorvine, Martin
|
|
2011
|
|
9 |
p. 431-432
2 p.
|
artikel
|
| 38 |
Guiding your patients through the Internet cancer information swamp
|
Fried, John J.
|
|
2011
|
|
9 |
p. 429-430
2 p.
|
artikel
|
| 39 |
Healthcare and clinical research: a critical link through standards
|
Kush, Rebecca Daniels
|
|
2007
|
|
9 |
p. 553-557
5 p.
|
artikel
|
| 40 |
Heeding Senator Kennedy's legacy
|
Schwartzberg, Lee S.
|
|
2009
|
|
9 |
p. 387-
1 p.
|
artikel
|
| 41 |
Helping patients meet their financial obligations: skills needed and actions you should take
|
Pilley, Karen
|
|
2008
|
|
9 |
p. 526-528
3 p.
|
artikel
|
| 42 |
Insurance coverage for rare cancers: the carrier's perspective
|
Klepper, Brian
|
|
2006
|
|
9 |
p. 553-554
2 p.
|
artikel
|
| 43 |
Intravenous iron in chemotherapy and cancer-related anemia
|
Auerbach, Michael
|
|
2012
|
|
9 |
p. 289-295
7 p.
|
artikel
|
| 44 |
Ipilimumab improves survival in previously treated metastatic melanoma
|
Abraham, Jame
|
|
2010
|
|
9 |
p. 395-396
2 p.
|
artikel
|
| 45 |
Liposomal doxorubicin extravasation
|
Held-Warmkessel, Jeanne
|
|
2007
|
|
9 |
p. 527-
1 p.
|
artikel
|
| 46 |
Liposomal doxorubicin extravasation
|
Laufman, Leslie R.
|
|
2007
|
|
9 |
p. 527-
1 p.
|
artikel
|
| 47 |
Liver-directed therapies for hepatocellular cancer
|
Choi, Minsig
|
|
2007
|
|
9 |
p. 571-575
5 p.
|
artikel
|
| 48 |
Living with metastatic breast cancer: a global patient survey
|
Mayer, Musa
|
|
2010
|
|
9 |
p. 406-412
7 p.
|
artikel
|
| 49 |
Lymphoid malignancies: a previously unrecognized risk factor for bone loss
|
Laufman, Leslie R.
|
|
2007
|
|
9 |
p. 561-563
3 p.
|
artikel
|
| 50 |
Management of febrile neutropenia
|
Kannangara, Saman
|
|
2006
|
|
9 |
p. 585-591
7 p.
|
artikel
|
| 51 |
Managing the side effects of sorafenib and sunitinib
|
Wood, Laura S.
|
|
2006
|
|
9 |
p. 558-562
5 p.
|
artikel
|
| 52 |
Mandibular fracture in a patient treated with long-term antiangiogenic therapy and previous bisphosphonate exposure
|
Davis, Tyler
|
|
2011
|
|
9 |
p. 415-417
3 p.
|
artikel
|
| 53 |
Medicare Shared Savings Program ignores oncology—but value-based reimbursement is on the way
|
Brow, Matthew E.
|
|
2011
|
|
9 |
p. 423-424
2 p.
|
artikel
|
| 54 |
Missing data
|
Streiner, David L.
|
|
2010
|
|
9 |
p. 429-431
3 p.
|
artikel
|
| 55 |
Molecular tumor profile: another consideration for postmastectomy radiotherapy
|
Pollock, Jondavid
|
|
2011
|
|
9 |
p. 427-
1 p.
|
artikel
|
| 56 |
Muir-Torre syndrome associated with a mutation in MSH6: multiple sebaceous carcinomas as the presenting feature
|
Cohen, Stephanie A.
|
|
2009
|
|
9 |
p. 418-421
4 p.
|
artikel
|
| 57 |
Mycosis fungoides and Sézary syndrome: the burden of pruritus
|
Demierre, Marie-France
|
|
2010
|
|
9 |
p. 399-404
6 p.
|
artikel
|
| 58 |
Navigating the drug shortages
|
Hambrick, Douglas
|
|
2012
|
|
9 |
p. 296-297
2 p.
|
artikel
|
| 59 |
No quick fix for drug errors, but it can be done
|
Finkelstein, Joel B.
|
|
2006
|
|
9 |
p. 609-610
2 p.
|
artikel
|
| 60 |
Oncology addresses the impending doctor gap
|
Young, Patrick
|
|
2010
|
|
9 |
p. 432-
1 p.
|
artikel
|
| 61 |
Oxaliplatin-induced eosinophilic pneumonia: a case report and review of the literature
|
Vu, Kevin
|
|
2009
|
|
9 |
p. 422-424
3 p.
|
artikel
|
| 62 |
Personalized medicine: myth to reality
|
Abraham, Jame
|
|
2011
|
|
9 |
p. 395-396
2 p.
|
artikel
|
| 63 |
Polysorbate 80 hypersensitivity reactions: a renewed call to action
|
Norris, LeAnn B.
|
|
2010
|
|
9 |
p. 425-428
4 p.
|
artikel
|
| 64 |
Progressive multifocal leukoencephalopathy following rituximab treatment
|
Frick, Melissa
|
|
2009
|
|
9 |
p. 410-411
2 p.
|
artikel
|
| 65 |
Prostate cancer in men 40 years of age and younger: report of two cases
|
Reyes, Cesar V.
|
|
2009
|
|
9 |
p. 425-427
3 p.
|
artikel
|
| 66 |
Prostate cancer in younger men poses clinical and research challenges
|
Dorff, Tanya
|
|
2009
|
|
9 |
p. 427-
1 p.
|
artikel
|
| 67 |
Quality care is a team effort
|
Bosserman, Linda D.
|
|
2011
|
|
9 |
p. 405-408
4 p.
|
artikel
|
| 68 |
Quality of life: attention must be paid to patients' symptoms
|
Schwartzberg, Lee S.
|
|
2010
|
|
9 |
p. 389-
1 p.
|
artikel
|
| 69 |
Risk assessment and genetic counseling for multiple endocrine neoplasia type 1 (MEN1)
|
Rich, Thereasa A.
|
|
2008
|
|
9 |
p. 502-510
9 p.
|
artikel
|
| 70 |
Sizing up the costs and availability of drugs
|
Abraham, Jame
|
|
2012
|
|
9 |
p. 269-
1 p.
|
artikel
|
| 71 |
Sorafenib in advanced HCC
|
Abraham, Jame
|
|
2007
|
|
9 |
p. 528-529
2 p.
|
artikel
|
| 72 |
Sorafenib: new reference standard for systemic treatment of advanced hepatocellular carcinoma
|
Lau, Yiu-Keung
|
|
2007
|
|
9 |
p. 529-530
2 p.
|
artikel
|
| 73 |
Staying focused on the practical
|
Schwartzberg, Lee S.
|
|
2006
|
|
9 |
p. 547-
1 p.
|
artikel
|
| 74 |
Staying UpToDate
|
Fried, John J.
|
|
2006
|
|
9 |
p. 600-
1 p.
|
artikel
|
| 75 |
Surgical resection of liver metastasis from colorectal cancer: targeting local therapy to systemic disease
|
Howard IV, Frank D.
|
|
2006
|
|
9 |
p. 571-
1 p.
|
artikel
|
| 76 |
The drug shortages: seeking a national-level solution
|
Patt, Debra A.
|
|
2012
|
|
9 |
p. 277-
1 p.
|
artikel
|
| 77 |
The emerging role of novel therapeutic agents in the management of patients with multiple myeloma
|
Ghobrial, Irene M.
|
|
2006
|
|
9 |
p. 575-582
8 p.
|
artikel
|
| 78 |
The financial and economic concerns
|
Policicchio, Patricia A.
|
|
2007
|
|
9 |
p. 530-
1 p.
|
artikel
|
| 79 |
The wearable external cardiac defibrillator for cancer patients at risk for sudden cardiac death
|
Everitt, Melanie D.
|
|
2011
|
|
9 |
p. 400-403
4 p.
|
artikel
|
| 80 |
10 Tips for implementing quality improvement in oncology practice
|
Lichter, Allen S.
|
|
2011
|
|
9 |
p. 408-409
2 p.
|
artikel
|
| 81 |
Why prevention must prevail
|
Feinberg, Bruce A.
|
|
2009
|
|
9 |
p. 394-395
2 p.
|
artikel
|
Tijdschrift beschrijving